Dutasteride And Tamsulosin Hydrochloride Capsule
Product Images NDC 59651-063

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dutasteride And Tamsulosin Hydrochloride (NDC 59651-063). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. International Prostate Symptom Score Change From Baseline Over A 48-month Period (randomized, Double-blind, Parallel-group Trial [combat Trial]) (Dutatamsulosin Fig1)

This information appears to show the mean change from baseline in IPSS (International Prostate Symptom Score) over multiple months of treatment for three different groups: Dutasteride + Tamsulosin, Dutasteride 0.5 mg, and Tamsulosin 0.4 mg. The sample size for each group is given for each month of treatment.*

FDA Label Image

Figure2 (Dutatamsulosin Fig2)

This appears to be a chart showing the mean change from baseline in milliseconds over months of treatment for different groups receiving different medications. The groups include those receiving Dutasteride+ Tamsulosin, Dutasteride 0.5 mg, and Enadosine 5 mg. The number of participants in each group is also provided. These metrics are likely part of a study or clinical trial evaluating the effects of these medications on the specified outcome.*

FDA Label Image

Package Label-principal Display Panel (0.5 mg/0.4 mg (30 Capsules Bottle))

This text provides important information about a medication called Dutasteride and Tamsulosin Hydrochloride Capsules. It includes details about dosage, handling warnings for women and children, and storage instructions. The capsules should be swallowed whole and not chewed or opened. The medication contains 0.5 mg of dutasteride USP and 0.4 mg of tamsulosin hydrochloride USP. The manufacturer is Aurobindo Pharma USA, Inc., and the product is distributed in the United States. It also includes a code and details about packaging and labeling.*

FDA Label Image

Package Label-principal Display Panel (0.5 mg/0.4 mg (90 Capsules Bottle))

This text provides information about a medication in capsule form containing dutasteride and tamsulosin, distributed by Aurobindo Pharma USA, Inc. Each capsule contains 0.5mg of dutasteride USP and 0.4mg of tamsulosin hydrochloride USP. The usual dosage is one capsule daily, and it is advised to swallow them whole and not chew or open them. There is a warning that these capsules should not be used by women or children, especially pregnant women. The text also includes details on storage conditions and contact information for further details. It is specified that the capsules should not be used if the printed safety seal under the cap is broken or missing.*

FDA Label Image

Chemical Structure 1 (Dutatamsulosin Str1)

FDA Label Image

Chemical Structure 2 (Dutatamsulosin Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.